Last reviewed · How we verify

Technescan Pyp (sodium pyrophosphate)

FDA-approved active ✓ Verified May 2026 Quality 20/100

Technescan Pyp (generic name: sodium pyrophosphate) is a drug. It is currently FDA-approved.

Technescan PYP is a technetium-99m labeled small molecule, specifically a tetrasodium pyrophosphate compound, used in medical imaging for conditions such as Systemic Amyloidosis. It is administered as 99mTc-p5+14, an amyloid reactive peptide labeled with technetium-99m, for diagnostic purposes.

At a glance

Generic namesodium pyrophosphate
TargetFarnesyl pyrophosphate synthase
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Technescan Pyp

What is Technescan Pyp?

Technescan Pyp (sodium pyrophosphate) is a pharmaceutical drug.

What is the generic name of Technescan Pyp?

sodium pyrophosphate is the generic (nonproprietary) name of Technescan Pyp.

What development phase is Technescan Pyp in?

Technescan Pyp is FDA-approved (marketed).

What are the side effects of Technescan Pyp?

Common side effects of Technescan Pyp include Flushing, Hypotension, Fever, Chills, Nausea, Vomiting. Serious adverse events: Hypersensitivity reactions.

What does Technescan Pyp target?

Technescan Pyp targets Farnesyl pyrophosphate synthase.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing